These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 5717554)
1. Micro modification of the dilute blood clot lysis time for determining fibrinolytic activity. Spittle CR; Lansdown NM; Hawkey CM J Clin Pathol; 1968 Nov; 21(6):780-1. PubMed ID: 5717554 [No Abstract] [Full Text] [Related]
2. Fibrinolytic activities of euglobulins precipitated at pH 6.4,6.0, and 5.3. Hedlin AM; Monkhouse FC Can J Physiol Pharmacol; 1969 Nov; 47(11):935-40. PubMed ID: 4242858 [No Abstract] [Full Text] [Related]
3. Assessment of fibrinolytic activity by measuring the lysis time of a tissue-factor-induced clot: a feasibility evaluation. Cellai AP; Lami D; Magi A; Liotta AA; Rogolino A; Antonucci E; Bandinelli B; Abbate R; Prisco D Clin Appl Thromb Hemost; 2010 Jun; 16(3):337-44. PubMed ID: 19117964 [TBL] [Abstract][Full Text] [Related]
4. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives. Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462 [TBL] [Abstract][Full Text] [Related]
5. Bidirectional functions of thrombin on fibrinolysis: Evidence of thrombin-dependent enhancement of fibrinolysis provided by spontaneous plasma clot lysis. Tomczyk M; Suzuki Y; Sano H; Brzoska T; Tanaka H; Urano T Thromb Res; 2016 Jul; 143():28-33. PubMed ID: 27179129 [TBL] [Abstract][Full Text] [Related]
6. Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of platelets. Taylor FB; Müller-Eberhard HJ J Clin Invest; 1970 Nov; 49(11):2068-85. PubMed ID: 4248913 [TBL] [Abstract][Full Text] [Related]
7. Clot life span model analysis of clot growth and fibrinolysis in normal subjects: role of thrombin activatable fibrinolysis inhibitor. Nielsen VG Blood Coagul Fibrinolysis; 2008 Jun; 19(4):283-7. PubMed ID: 18469549 [TBL] [Abstract][Full Text] [Related]
8. [The effect of heparin on the proteolytic and fibrinolytic activity on plasmin(ogen) and fibrin clot lysis]. Kudinov SA; Kolesnik LA; Makogonenko EM; Shuliakovskaia TA Biokhimiia; 1989 Nov; 54(11):1881-7. PubMed ID: 2534055 [TBL] [Abstract][Full Text] [Related]
11. Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis. Konieczynska M; Fil K; Bazanek M; Undas A Thromb Haemost; 2014 Apr; 111(4):685-93. PubMed ID: 24306139 [TBL] [Abstract][Full Text] [Related]
12. Biochemical and biophysical conditions for blood clot lysis. Sabovic M; Blinc A Pflugers Arch; 2000; 440(5 Suppl):R134-6. PubMed ID: 11005642 [TBL] [Abstract][Full Text] [Related]
13. Effects of gastric bypass followed by a randomized study of physical training on markers of coagulation activation, fibrin clot properties, and fibrinolysis. Stolberg CR; Mundbjerg LH; Funch-Jensen P; Gram B; Juhl CB; Bladbjerg EM Surg Obes Relat Dis; 2018 Jul; 14(7):918-926. PubMed ID: 29706497 [TBL] [Abstract][Full Text] [Related]
14. Influence of moderate and strenuous daily physical activity on fibrinolytic activity of blood: possibility of plasminogen activator stores depletion. Keber D; Stegnar M; Keber I; Accetto B Thromb Haemost; 1979 Jun; 41(4):745-55. PubMed ID: 483247 [TBL] [Abstract][Full Text] [Related]
15. Sodium acetate buffer: a diluent of choice in the clot lysis time technique. Chohan IS; Vermylen J; Singh I; Balakrishnan K; Verstraete M Thromb Diath Haemorrh; 1975 Apr; 33(2):226-9. PubMed ID: 1138420 [TBL] [Abstract][Full Text] [Related]
16. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters. Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650 [TBL] [Abstract][Full Text] [Related]
17. Plasminogen and urokinase determination based on the lysis time method. Purification of the substrates--kinetic and methodological studies. Berg W Acta Med Scand Suppl; 1967; 478():1-45. PubMed ID: 4231608 [No Abstract] [Full Text] [Related]
18. A precise and rapid microtitre plate clot lysis assay: methodology, kinetic modeling and measurement of catalytic constants for plasminogen activation during fibrinolysis. Jones AJ; Meunier AM Thromb Haemost; 1990 Nov; 64(3):455-63. PubMed ID: 2128976 [TBL] [Abstract][Full Text] [Related]
19. The impact of the endothelial protein C receptor on thrombin generation and clot lysis. Pepler L; Wu C; Dwivedi DJ; Wu C; Kim PY; Liaw PC Thromb Res; 2017 Apr; 152():30-37. PubMed ID: 28219843 [TBL] [Abstract][Full Text] [Related]
20. Effect of remote ischaemic conditioning on coagulation and fibrinolysis. Kristiansen J; Grove EL; Rise N; Neergaard-Petersen S; Würtz M; Kristensen SD; Hvas AM Thromb Res; 2016 May; 141():129-35. PubMed ID: 27018926 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]